124 related articles for article (PubMed ID: 1640710)
1. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Içli F; Günel N; Dinçol D; Karaoğuz H; Demirkazik A
J Surg Oncol; 1992 Aug; 50(4):251-3. PubMed ID: 1640710
[TBL] [Abstract][Full Text] [Related]
2. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
Colozza M; Tonato M; Grignani F; Davis S
Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
[TBL] [Abstract][Full Text] [Related]
3. [Cisplatin and vinorelbine therapy of previously treated advanced breast cancer (preliminary studies)].
Szatkowska L; Mazurkiewicz M; Brzozowska A
Pol Merkur Lekarski; 2001 Mar; 10(57):148-9. PubMed ID: 11398513
[TBL] [Abstract][Full Text] [Related]
4. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
[TBL] [Abstract][Full Text] [Related]
5. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Chahinian AP; Green G; Holland JF
Am J Clin Oncol; 1984 Oct; 7(5):419-23. PubMed ID: 6439029
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide, methotrexate,5-fluorouracil, alternating with adriamycin and mitomycin C in metastatic breast cancer: a pilot study.
Cruciani G; Tienghi A; Molinari AL; Fiorentini G; Rosti G; Turci D; Marangolo M
Tumori; 1987 Jun; 73(3):303-7. PubMed ID: 3111046
[TBL] [Abstract][Full Text] [Related]
8. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
9. Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Theriault RL; Hortobagyi GN; Kau SW; Holmes FA; Hug V; Fraschini G; Jabboury K; Buzdar AU
Cancer; 1988 Nov; 62(10):2105-10. PubMed ID: 3179923
[TBL] [Abstract][Full Text] [Related]
10. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
11. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
[TBL] [Abstract][Full Text] [Related]
12. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
Zhou JC
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
[TBL] [Abstract][Full Text] [Related]
14. Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.
Aldabbagh K; Pouderoux S; Roca L; Poujol S; Fabbro M; Romieu G; Jacot W
Breast Cancer; 2012 Jan; 19(1):16-22. PubMed ID: 21088942
[TBL] [Abstract][Full Text] [Related]
15. [Results of combination chemotherapy in advanced urothelial cancer].
Komatsubara S; Watanabe M; Kitamura Y; Sakata Y
Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
[TBL] [Abstract][Full Text] [Related]
16. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
18. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G
Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study.
Amoroso D; Pronzato P; Bertelli G; Gallotti P; Pastorino G; Cusimano MP; Merlano M; Conte PF; Rosso R
Breast Cancer Res Treat; 1988 Jul; 11(3):269-71. PubMed ID: 3167233
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy for advanced urothelial-tract carcinoma.
Sahashi M; Ono Y; Matsuura O; Ohshima S; Fukushima M
Cancer Chemother Pharmacol; 1992; 30 Suppl():S59-62. PubMed ID: 1394820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
